209 - Combatting Viral Sexually Transmitted Infections

Saturday, October 14, 2023

10:30 AM – 11:45 AM US ET

Location: 153 ABC

All relevant financial disclosures have been mitigated.

Moderator(s)

Christine Johnston, MD, MPH (she/her/hers)

Associate Professor
Medicine
University of Washington
Seattle, WA, United States
Joseph Cherabie, MD, MSc (they/them/theirs)

Assistant Professor
Washington University St. Louis
Saint Louis, MO, United States

Faculty(s)

Jason Zucker, MD, MS

Assistant Professor of Medicine
Internal Medicine and Pediatrics
Columbia University Irving Medical Center
New York, NY, United States

Slides
Anna Wald, MD, MPH

Professor
University of Washington
Seattle, WA, United States

Slides
LM

Lauri Markowitz, MD

Team Lead HPV, Associate Director for Science
Centers for Disease Control and Prevention
Atlanta, GA, United States

Disclosure(s):

Christine Johnston, MD, MPH: Assembly Biosciences: Advisor/Consultant (Ongoing); Gilead: Grant/Research Support (Ongoing); GSK: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: Royalties (Ongoing)

Joseph Cherabie, MD, MSc: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

explain current advances and opportunities in management of genital herpes;
describe MPOX epidemiology, successes, and challenges from the 2022 pandemic;
describe how HPV vaccination has impacted HPV epidemiology and HPV-associated disease

Presentations:

10:30 AM – 10:55 AM US ET

Mpox One Year On: What Have We Learned?
Speaker: Jason Zucker, MD, MS – Columbia University Irving Medical Center
10:55 AM – 11:20 AM US ET

Genital Herpes: Expanding the Toolbox
Speaker: Anna Wald, MD, MPH – University of Washington
11:20 AM – 11:45 AM US ET

How HPV Vaccination Has Changed HPV Epidemiology and HPV-Related Disease
Speaker: Lauri E. Markowitz, MD – Centers for Disease Control and Prevention